Originally identified in sleep-related research. Its role remains an ongoing area of investigation.
DSIP
Delta sleep-inducing peptide is a nonapeptide first isolated in the 1970s by Schoenenberger and Monnier, from the cerebral venous blood of rabbits in induced slow-wave sleep. Its name records the circumstances of its discovery rather than a confirmed mechanism.
That naming is the interesting problem. The peptide was identified by association with a physiological state, then studied for decades without a settled account of what it does or which receptor it acts on. Fifty years later it remains one of the more mechanistically ambiguous peptides in continued circulation, which is the reason it appears in research catalogues rather than pharmacies.
The literature covers sleep architecture in animal models, stress physiology, and endocrine interactions, with a scattering of small human studies from the 1980s. Findings have been inconsistent across groups, and no receptor has been definitively characterised. Anyone reading this literature should expect ambiguity rather than convergence.